ARCOMA Stock Overview
Arcoma AB develops, produces, and provides radiology solutions worldwide.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 4/6 |
| Past Performance | 5/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Arcoma AB Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | kr11.90 |
| 52 Week High | kr13.00 |
| 52 Week Low | kr6.30 |
| Beta | 0.98 |
| 1 Month Change | 0% |
| 3 Month Change | 51.59% |
| 1 Year Change | 23.96% |
| 3 Year Change | -43.06% |
| 5 Year Change | -47.35% |
| Change since IPO | -13.14% |
Recent News & Updates
Arcoma AB's (STO:ARCOMA) P/E Is Still On The Mark Following 25% Share Price Bounce
Feb 06
Is Arcoma (STO:ARCOMA) A Risky Investment?
Jan 15Recent updates
Arcoma AB's (STO:ARCOMA) P/E Is Still On The Mark Following 25% Share Price Bounce
Feb 06Is Arcoma (STO:ARCOMA) A Risky Investment?
Jan 15We Think Arcoma (STO:ARCOMA) Is Taking Some Risk With Its Debt
Sep 11Is Arcoma (STO:ARCOMA) Using Too Much Debt?
Jun 08Is Arcoma AB (STO:ARCOMA) Potentially Undervalued?
Apr 27Does Arcoma (STO:ARCOMA) Have A Healthy Balance Sheet?
Dec 22Is Arcoma (STO:ARCOMA) Using Too Much Debt?
May 03These 4 Measures Indicate That Arcoma (STO:ARCOMA) Is Using Debt Extensively
Oct 28Is Arcoma (STO:ARCOMA) A Risky Investment?
Mar 17Is Arcoma AB (STO:ARCOMA) Potentially Undervalued?
Feb 04Have Insiders Sold Arcoma AB (STO:ARCOMA) Shares Recently?
Jan 14
Arcoma AB's (STO:ARCOMA) Stock's On An Uptrend: Are Strong Financials Guiding The Market?
Jan 12These 4 Measures Indicate That Arcoma (STO:ARCOMA) Is Using Debt Reasonably Well
Dec 17Estimating The Fair Value Of Arcoma AB (STO:ARCOMA)
Nov 21Shareholder Returns
| ARCOMA | SE Medical Equipment | SE Market | |
|---|---|---|---|
| 7D | 1.7% | 1.6% | 1.8% |
| 1Y | 24.0% | -9.0% | 10.7% |
Return vs Industry: ARCOMA exceeded the Swedish Medical Equipment industry which returned -13.6% over the past year.
Return vs Market: ARCOMA exceeded the Swedish Market which returned 7.8% over the past year.
Price Volatility
| ARCOMA volatility | |
|---|---|
| ARCOMA Average Weekly Movement | 7.7% |
| Medical Equipment Industry Average Movement | 6.9% |
| Market Average Movement | 6.1% |
| 10% most volatile stocks in SE Market | 12.9% |
| 10% least volatile stocks in SE Market | 3.5% |
Stable Share Price: ARCOMA's share price has been volatile over the past 3 months.
Volatility Over Time: ARCOMA's weekly volatility (8%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1990 | 31 | Mattias Leire | www.arcoma.se |
Arcoma AB develops, produces, and provides radiology solutions worldwide. It offers digital x-ray systems for radiographic applications, as well as for use in general, eneral, muscle/skeleton, thoratic, pediatric, and trauma/resus clinics. The company sells its products through OEM partners.
Arcoma AB Fundamentals Summary
| ARCOMA fundamental statistics | |
|---|---|
| Market cap | kr156.91m |
| Earnings (TTM) | kr2.56m |
| Revenue (TTM) | kr163.02m |
61.2x
P/E Ratio1.0x
P/S RatioIs ARCOMA overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ARCOMA income statement (TTM) | |
|---|---|
| Revenue | kr163.02m |
| Cost of Revenue | kr105.10m |
| Gross Profit | kr57.91m |
| Other Expenses | kr55.35m |
| Earnings | kr2.56m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
Apr 25, 2024
| Earnings per share (EPS) | 0.19 |
| Gross Margin | 35.53% |
| Net Profit Margin | 1.57% |
| Debt/Equity Ratio | 8.0% |
How did ARCOMA perform over the long term?
See historical performance and comparison